Amcor shares surge 7.86% after hours as Baird raises price target to $54 on strong earnings and Berry integration synergies.

Amcor surged 7.86% in after-hours trading following a strategic update on Berry Global integration and a bullish analyst upgrade. The company reported $55 million in Q2 synergies from the acquisition, exceeding guidance, and outlined $260 million in FY2026 targets through operational restructuring, site closures, and procurement efficiencies. Additionally, Amcor highlighted a new GLP-1 pharmaceutical packaging contract and reaffirmed FY2026 earnings guidance. Baird upgraded the stock to $54 (from $50) while maintaining an Outperform rating, citing low double-digit earnings growth from synergies and improving end-market fundamentals. These developments collectively reinforced investor confidence in Amcor’s cost discipline, strategic focus, and emerging healthcare opportunities.